MeSH term | MeSH ID | Detail |
---|---|---|
Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Hypercholesterolemia | D006937 | 91 associated lipids |
tritriacontanoic acid is a lipid of Fatty Acyls (FA) class. Tritriacontanoic acid is associated with abnormalities such as hypercholesterolemia, Metabolic syndrome, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Insulin-Dependent and Parkinson Disease. The involved functions are known as Fermentation, Process, Longterm Effects, Pressure- physical agent and Lipid Metabolism. Tritriacontanoic acid often locates in Blood, Tissue fiber and A Fibers. The associated genes with tritriacontanoic acid are STN gene. The related lipids are Total cholesterol and blood lipid.
To understand associated biological information of tritriacontanoic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
tritriacontanoic acid is suspected in hypercholesterolemia, Metabolic syndrome, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Insulin-Dependent, Parkinson Disease and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with tritriacontanoic acid
MeSH term | MeSH ID | Detail |
---|---|---|
Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Hypercholesterolemia | D006937 | 91 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Sierra M et al. | Therapeutic effects of psyllium in type 2 diabetic patients. | 2002 | Eur J Clin Nutr | pmid:12209371 |
Romero AL et al. | The seeds from Plantago ovata lower plasma lipids by altering hepatic and bile acid metabolism in guinea pigs. | 2002 | J. Nutr. | pmid:12042433 |
Plantago ovata. (Psyllium). | 2002 | Altern Med Rev | pmid:11991795 | |
Jenkins DJ et al. | Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. | 2002 | Am. J. Clin. Nutr. | pmid:11976156 |
RodrÃguez-Cabezas ME et al. | Intestinal anti-inflammatory activity of dietary fiber (Plantago ovata seeds) in HLA-B27 transgenic rats. | 2003 | Clin Nutr | pmid:14512034 |
Vega-López S et al. | Sex and hormonal status modulate the effects of psyllium on plasma lipids and monocyte gene expression in humans. | 2003 | J. Nutr. | pmid:12514268 |
Khalili B et al. | Psyllium-associated anaphylaxis and death: a case report and review of the literature. | 2003 | Ann. Allergy Asthma Immunol. | pmid:14700444 |
Gohel MC et al. | Development of modified release diltiazem HCl tablets using composite index to identify optimal formulation. | 2003 | Drug Dev Ind Pharm | pmid:12779286 |
Salguero Molpeceres O et al. | [Esophageal obstruction caused by dietary fiber from Plantago ovata, a complication preventable by adequate information]. | 2003 | Gastroenterol Hepatol | pmid:12681118 |
Yu LL and Perret J | Effects of xylanase treatments on gelling and water-uptaking properties of psyllium. | 2003 | J. Agric. Food Chem. | pmid:12517115 |